RJA
MTEM

Raymond James & Associates’s Molecular Templates, Inc. MTEM Stock Holding History

Raymond James & Associates’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-770
Closed -$3.79K – 4125
2022
Q4 		$3.79K Hold
770
– – ﹤0.01% 3888
2022
Q3 		$9K Hold
770
– – ﹤0.01% 3867
2022
Q2 		$11K Buy
+770
New +$18K ﹤0.01% 3933

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Raymond James & Associates's MTEM Position: Q1 2023 in Review

Raymond James & Associates sold out of Molecular Templates, Inc. (MTEM) in Q1 2023, closing a stake of 770 shares — an estimated $3.79K sold.

Raymond James & Associates first reported a position in MTEM in Q2 2022 and held it in 3 quarters. The position peaked at $11K in Q2 2022. 41 funds tracked by Wall St. Rank hold MTEM as of Q1 2023.

  • Raymond James & Associates reported no remaining Molecular Templates, Inc. position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 770 Molecular Templates, Inc. shares in Q1 2023, an estimated $3.79K.
  • Raymond James & Associates first reported a position in Molecular Templates, Inc. in Q2 2022 and held it in 3 quarters.
  • Raymond James & Associates's Molecular Templates, Inc. position peaked at $11K in Q2 2022.
  • 41 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.